Retatrutide: a research dosing guide

A long-acting acylated peptide, Retatrutide (LY3437943) activates three receptors at once: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and the glucagon receptor (GCGR). CAS: 2381879-91-8.

It arrived as a next-generation metabolic peptide on the heels of semaglutide (GLP-1 mono) and tirzepatide (GLP-1/GIP dual); the reasoning is that layering glucagon agonism on top pushes energy expenditure higher than dual agonism manages by itself.

Retatrutide is research-use only and holds no regulatory approval for clinical or therapeutic application.

GLP-1 receptor (GLP-1R): Found across the pancreas, brain (hypothalamus), gut, heart and kidney. Switching on GLP-1R dampens appetite centrally, delays gastric emptying and drives glucose-dependent insulin release.

GIP receptor (GIPR): Present in adipose tissue, bone, brain and pancreatic beta cells. GIP exerts intricate, context-sensitive effects on fat metabolism and may reinforce GLP-1R signalling.

Glucagon receptor (GCGR): Concentrated mainly in the liver and brown adipose tissue. Glucagon raises hepatic glucose output while promoting lipolysis and thermogenesis. When GLP-1R agonism runs alongside it — offsetting hyperglycaemia — the net glucagon effect can lift energy expenditure in research models without producing clinically meaningful hyperglycaemia.

Eli Lilly's Phase 2 trial (NCT04881760) evaluated weekly subcutaneous doses climbing from 1 mg up to 12 mg in participants with obesity. By the 24-week mark, the highest-dose group recorded an average weight drop of roughly 17.5% relative to baseline.

In vitro receptor-binding assays generally prepare Retatrutide as a 10 mM stock in DMSO, then dilute it in assay buffer down to the target concentration.

Published mouse pharmacokinetic studies report subcutaneous dosing in the 1–10 nmol/kg range. These figures apply to animal-model research only and do not translate to human subjects.

Retatrutide arrives as a lyophilized powder. For research handling:

• Reconstitute with bacteriostatic water (the preferred choice for multi-dose vials) or sterile PBS
• A common research stock concentration is 1 mg/mL
• Hold the reconstituted solution at 4 °C for as long as 28 days; once reconstituted, do not freeze-thaw it
• Keep it away from UV light

German Aminos Retatrutide undergoes independent HPLC testing — backed by NMR structural confirmation — to verify ≥ 99% purity. You can download the CoA directly from the Lab Results page or from any product listing.